Open Access
Research (Published online: 27-03-2018)
18. Evaluation of antimycobacterial activity of Curcuma xanthorrhiza ethanolic extract against Mycobacterium tuberculosis H37Rv in vitro
Ngadino, Setiawan, Koerniasari, Ernawati and S. A. Sudjarwo
Veterinary World, 11(3): 368-372

Ngadino: Study Program of Environmental Health, Polytechnic of Health, Surabaya, Indonesia.
Setiawan: Study Program of Environmental Health, Polytechnic of Health, Surabaya, Indonesia.
Koerniasari: Study Program of Environmental Health, Polytechnic of Health, Surabaya, Indonesia.
Ernawati: Department of Pharmacology, Faculty of Medicine, Wijaya Kusuma University, Surabaya, Indonesia.
S. A. Sudjarwo: Department of Pharmacology, Faculty of Veterinary Medicine, Airlangga University, Surabaya, Indonesia.

doi: 10.14202/vetworld.2018.368-372

Share this article on [Facebook] [LinkedIn]

Article history: Received: 09-12-2017, Accepted: 20-02-2018, Published online: 27-03-2018

Corresponding author: S. A. Sudjarwo

E-mail: ags158@yahoo.com

Citation: Ngadino, Setiawan, Koerniasari, Ernawati, Sudjarwo SA (2018) Evaluation of antimycobacterial activity of Curcuma xanthorrhiza ethanolic extract against Mycobacterium tuberculosis H37Rv in vitro, Veterinary World, 11(3): 368-372.
Abstract

Aim: The aim of this study was to evaluate the antimycobacterial activity of the Curcuma xanthorrhiza ethanolic extract in vitro.

Materials and Methods: Ethanolic extract of C. xanthorrhiza was set by maceration method. The broth microdilution and disc diffusion method were used to determine the minimal inhibitory concentration (MIC) and minimal bactericidal concentration (MBC), respectively, of C. xanthorrhiza ethanol extract on strain Mycobacterium tuberculosis H37Rv.

Results: C. xanthorrhiza ethanol extract was found to have the antimycobacterial effects with a MIC value of 1600 μg/ml while MBC value of 3200 μg/ml for M. tuberculosis H37Rv.

Conclusion: From these findings , it can be concluded that C. xanthorrhiza ethanol extract have an antibacterial activity against Mycobacterium tuberculosis H37Rv in vitro and its potency elevated by increasing the C. xanthorrhiza ethanol extract concentration.

Keywords: antimycobacterial, Curcuma xanthorrhiza, minimal bactericidal concentration, minimal inhibitory concentration.

References

1. World Health Organization. Global Tuberculosis Report. (2015). WHO, Geneva, Switzerland. p1-145.

2. Cragg, G.M. and Newman, D.J. (2013) Natural products: A continuing source of novel drug. Biochim. Biophys. Acta., 1830: 3670-3695. [Crossref] [PubMed] [PMC]

3. Sudjarwo, S.A. and Koerniasari, G.W. (2017) Protective effect of curcumin on lead acetate-induced testicular toxicity in Wistar rats. Res. Pharm. Sci., 12: 381-390. [Crossref] [PubMed] [PMC]

4. Jyoti, S. and Rajeshwari, S. (2012) Evaluation of phytochemical constituents in conventional and non-conventional species of curcuma. Int. Res. J. Pharm., 3: 203-204.

5. Njeru, S.N., Obonyo, M.A., Ngari, S.M., Njeru, J.M. and Kamweru, P.P. (2015) Antituberculous, antimicrobial, cytotoxicity and phytochemical activity study of Piliostigma thonningii extract fractions. J. Med. Plants Res., 9: 655-663. [Crossref]

6. Fadipe, V.O., Opoku, A.R., Dikhoba, P.M. and Makhafola T.J. (2017) Isolation of anti-mycobacterial compounds from Curtisia dentata (Burm.f.) C.A.Sm (Curtisiaceae). BMC Complement. Altern. Med., 17: 306-313. [Crossref] [PubMed] [PMC]

7. Nyambuya, T., Mautsa, R. and Mukanganyama, S. (2017) Alkaloid extracts from Combretum zeyheri inhibit the growth of Mycobacterium smegmatis. BMC Complement. Altern. Med., 17: 124-130. [Crossref] [PubMed] [PMC]

8. Naik, S.K., Mohanty, S., Padhi A., Pati, R. and Sonawane, A. (2014) Evaluation of antibacterial and cytotoxic activity of Artemisia nilagirica and Murraya koenigii leaf extracts against mycobacteria and macrophages. BMC Complement. Altern. Med., 14: 1-6. [Crossref] [PubMed] [PMC]

9. Oon, S.F., Nallappan, M., Tee, T.T., Shohaimi, S., Kassim, N.K. and Cheah, Y.H. (2015) Xanthorrhizol: A review of its pharmacological activities and anticancer properties. Cancer. Cell. Int., 15: 100. [Crossref] [PubMed] [PMC]

10. Sylvester, W.S., Son, R., Lew, K.F. and Rukayadi, Y. (2015) Antibacterial activity of java turmeric (Curcuma xanthorrhiza Roxb.) extract against Klebsiella pneumoniae isolated from several vegetables. Int. Food Res. J., 22: 1770-1776.

11. Lee, L.Y., Shim, J.S., Rukayadi, Y. and Hwang, J.K. (2008) Antibacterial activity of xanthorrhizol isolated Curcuma xanthorrhiza Roxb. against food borne pathogens. J. Food Prot., 71: 1926-1930. [Crossref] [PubMed]

12. Tyagi, P., Singh, M., Kumari, H., Kumari, A. and Mukhopadhyay K. (2015) Bactericidal activity of curcumin is associated with damaging of bacterial membrane. PLoS One., 10: e0121313-e0121328. [Crossref] [PubMed] [PMC]

13. Moghadamtousi, S.Z., Kadir, H.A., Hassandarvish, P., Tajik, H., Abubakar, S. and Zandi, K. (2014) A review on antibacterial, antiviral, and antifungal activity of curcumin. Biomed. Res. Int., 2014: 186864-186875. [PubMed]

14. Sudjarwo, S.A., Eraiko, K. and Koerniasari, G.W. (2011) Mechanisms of endothelial cell protection by curcumin in hypercholesterolemia. J. Appl. Pharm. Sci., 1: 32-35.

15. Sudjarwo, S.A., Eraiko, K. and Koerniasari, G.W. (2017) Antioxidant activity of curcumin as protector on methylmercury induced-pancreas damage in mice. J. Chin. Pharm. Sci., 26: 196-201.

16. Anjusha, S. and Gangaprasad, A. (2014) Phytochemical and antibacterial analysis of two important Curcuma species, Curcuma aromatica Salisb and Curcuma xanthorrhiza Roxb. (Zingiberaceae). J. Pharm. Phytochem., 3: 50-53.

17. Mary Helen, P.A., Susheela, G.K., Jayasree, S., Nizzy, A.M., Rajagopal, B. and Jeeva, S. (2012) Phytochemical characterization and antimicrobial activity of Curcuma xanthorrhiza Roxb. Asian. Pac. J. Trop. Biomed., 2: S637-S640. [Crossref]

18. Rai, D., Singh, J.K., Roy, N. and Panda, D. (2008) Curcumin inhibits FtsZ assembly: An attractive mechanism for its antibacterial activity. Biochem. J., 410: 147-155. [Crossref]

19. Primm, T.P. and Franzblau, S.G. (2007) Recent advances in methodologies for the discovery of anti-mycobacterial Drugs. Curr. Bioact. Compd., 3: 1-8. [Crossref]

20. Ang, C.F., Mendoza, M.T. and Bulatao, W.C. (2010) Evaluation of the resazurin microtiter assay for drug susceptibility testing of clinical isolates of Mycobacterium tuberculosis. J. Microbiol. Infect. Dis., 39: 59-65.